0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

JAUNDICE DUE TO METHYLTESTOSTERONE THERAPY

John C. Wood, M.D.
JAMA. 1952;150(15):1484-1486. doi:10.1001/jama.1952.63680150003009a.
Text Size: A A A
Published online

Methyltestosterone has been implicated as a cause of hepatogenous jaundice. The histological abnormality produced in the liver by this drug is said tc be distinctive. It consists of bile plugging of the intercellular canaliculi unaccompanied by notable inflammatory reaction or necrosis. Furthermore, the laboratory findings are of aid in the differentiation of methyltestosterone-induced icterus from other causes with which it may be confused clinically. The following report illustrates the characteristic features of jaundice caused by methyltestosterone therapy.

REPORT OF A CASE  M. L., aged 32, was admitted to the Hospital of the University of Pennsylvania on Oct. 11, 1950, with complaints of abdominal cramps and anorexia of two weeks' duration. During the week prior to admission he had one episode of vomiting. Subsequently he noted dark urine, light but not acholic stools, and generalized pruritus. His physician observed icterus on Oct. 10, 1950. The patient had received no parenteral medication;

Topics

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

62 Views
0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
×
brightcove.createExperiences();